問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2023-09-19

王亮人
  • Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

3Cases

2011-11-01 - 2013-12-31

Phase II

A randomized, double-blind, parallel-group study of the safety and efficacy of RO4917523 versus placebo, as adjunctive therapy in patients with major depressive disorder with inadequate response
  • Condition/Disease

    Major depressive disorder

  • Test Drug

    RO4917523

Participate Sites
3Sites

Terminated3Sites

2022-01-01 - 2024-04-09

Phase II

A Phase II Tolerability and Efficacy Study of PDC-1421 Treatment in Adult Patients with Attention-Deficit Hyperactivity Disorder (ADHD), Part II
  • Condition/Disease

    Attention-Deficit Hyperactivity Disorder (ADHD)

  • Test Drug

    PDC-1421 Capsule

Participate Sites
5Sites

Recruiting5Sites

2010-07-07 - 2013-06-08

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
10Sites

Terminated10Sites